Fig. 3From: Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy)Prevalence trend (2008–2017) of the investigated disease-modifying antirheumatic drugs (DMARDs): azathioprine, cyclophosphamide, ciclosporin, methotrexate, hydroxychloroquine, mycophenolic acid (as mycophenolate mofetil), and rituximabBack to article page